Swedish clinical-stage vaccine company
Novavax ▸ Facts ▸ Comments ▸ News ▸ Videos
Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.
You Might Like
No news matches foundSorry, we were unable to find any results in our database for your query
Free news archive access
Did you know?
You are eligible to search our news archive with millions of news references free of charge.
To do this, please sign in first at the top of the screen.
• Information about free access to our news archive
Search this site and the web: